Biomaterials in myocardial tissue engineering

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 1, 2016, Pages 11-28

  Reis, Lewis A ^a   Chiu, Loraine L Y ^b   Feric, Nicole ^a   Fu, Lara ^a   Radisic, Milica ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biomaterials; Cardiac regeneration; Cardiac scaffolds; Cardiac tissue engineering; Cardiac tissue models; Injectable hydrogels

Indexed keywords

BIOMATERIALS; DISEASES; HEART; HYDROGELS; REPAIR; SCAFFOLDS (BIOLOGY); TISSUE; TISSUE REGENERATION;

CARDIAC REGENERATION; CARDIAC SCAFFOLD; CARDIAC TISSUE ENGINEERING; CARDIAC TISSUE MODEL; CARDIAC TISSUES; CARDIOVASCULAR DISEASE; CAUSES OF DEATH; INJECTABLE HYDROGELS; MYOCARDIAL TISSUE ENGINEERING; TISSUE MODELS;

CARDIOLOGY;

ALGINIC ACID; BIOMATERIAL;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONGESTIVE CARDIOMYOPATHY; DECELLULARIZATION; EMBRYONIC STEM CELL; ENDOVENTRICULAR CIRCULAR PATCH PLASTY; EXTRACELLULAR MATRIX; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HEMATOPOIETIC STEM CELL; HUMAN; HYDROGEL; INJECTION; INTRACARDIAC PATCH; INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE PREPARATION; ANIMAL; CARDIAC MUSCLE; CHEMISTRY; DRUG EFFECTS; HEART; METABOLISM; PHYSIOLOGY; PROCEDURES; TISSUE SCAFFOLD;

ANIMALS; BIOCOMPATIBLE MATERIALS; HEART; HUMANS; INJECTIONS; MYOCARDIUM; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84954365832     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1944     Document Type: Article

References (93)

1. Akhyari P, Aubin H, Gwanmesia P, et al. 2011; The quest for an optimized protocol for whole-heart decellularization: a comparison of three popular and a novel decellularization technique and their diverse effects on crucial extracellular matrix qualities. Tissue Eng C Methods 17: 915-926.
2. Amir G, Miller L, Shachar M, et al. 2009; Evaluation of a peritoneal-generated cardiac patch in a rat model of heterotopic heart transplantation. Cell Transpl 18: 275-282.
3. Aubin H, Kranz A, Hulsmann J, et al. 2013; A novel native derived coronary artery tissue-flap model. Tissue Eng C Methods 19: 970-980.
4. Bhana B, Iyer RK, Chen WL, et al. 2010; Influence of substrate stiffness on the phenotype of heart cells. Biotechnol Bioeng 105: 1148-1160.
5. Bouten CV, Dankers PY, Driessen-Mol A, et al. 2011; Substrates for cardiovascular tissue engineering. Adv Drug Deliv Rev 63: 221-241.
6. Chen QZ, Harding SE, Ali NN, et al. 2008; Biomaterials in cardiac tissue engineering: Ten years of research survey. Mat Sci Eng R 59: 1-37.
7. Chiu LL, Radisic M. 2010; Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials 31: 226-241.
8. Chiu LL, Weisel RD, Li RK, et al. 2011; Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering. J Tissue Eng Regen Med 5: 69-84.
9. Chiu LL, Montgomery M, Liang Y, et al. 2012a; Perfusable branching microvessel bed for vascularization of engineered tissues. Proc Natl Acad Sci U S A 109: E3414-3423.
10. Chiu LL, Iyer RK, Reis LA, et al. 2012b; Cardiac tissue engineering: current state and perspectives. Frontiers Biosci 17: 1533-1550.
11. Christman KL, Fok HH, Sievers RE, et al. 2004a; Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 10: 403-409.
12. Christman KL, Vardanian AJ, Fang Q, et al. 2004b; Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 44: 654-660.
13. Dahl SL, Kypson AP, Lawson JH, et al. 2011; Readily available tissue-engineered vascular grafts. Sci Translat Med 3: 68ra69.
14. Dawson J, Schussler O, Al-Madhoun A, et al. 2011; Collagen scaffolds with or without the addition of RGD peptides support cardiomyogenesis after aggregation of mouse embryonic stem cells. In Vitro Cell Dev Biol Anim 47: 653-664.
15. Dvir T, Kedem A, Ruvinov E, et al. 2009; Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A 106: 14990-14995.
16. Eschenhagen T, Fink C, Remmers U, et al. 1997; Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 11: 683-694.
17. Fujimoto KL, Ma Z, Nelson DM, et al. 2009; Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials 30: 4357-4368.
18. Gnecchi M, Zhang ZP, Ni AG, et al. 2008; Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219.
19. Godier-Furnemont AF, Martens TP, Koeckert MS, et al. 2011; Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc Natl Acad Sci U S A 108: 7974-7979.
20. Guillemette MD, Park H, Hsiao JC, et al. 2010; Combined technologies for microfabricating elastomeric cardiac tissue engineering scaffolds. Macromol Biosci 10: 1330-1337.
21. Habib M, Shapira-Schweitzer K, Caspi O, et al. 2011; A combined cell therapy and in-situ tissue-engineering approach for myocardial repair. Biomaterials 32: 7514-7523.
22. Hilfiker A, Kasper C, Hass R, et al. 2011; Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation? Langenbeck's Arch Surg 396: 489-497.
23. Huang NF, Yu J, Sievers R, et al. 2005; Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng 11: 1860-1866.
24. Ifkovits JL, Tous E, Minakawa M, et al. 2010; Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci U S A 107: 11507-11512.
25. Jiang F, Zhang G, Hashimoto I, et al. 2008; Neovascularization in an arteriovenous loop-containing tissue engineering chamber: role of NADPH oxidase. J Cell Mol Med 12: 2062-2072.
26. Kirklin JK, Naftel DC, Kormos RL, et al. 2013; Fifth INTERMACS annual report: risk factor analysis from more than 6000 mechanical circulatory support patients. J Heart Lung Transpl 32: 141-156.
27. Kofidis T, Lenz A, Boublik J, et al. 2003; Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials 24: 5009-5014.
28. Kraehenbuehl TP, Ferreira LS, Zammaretti P, et al. 2009; Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials 30: 4318-4324.
29. Kraehenbuehl TP, Ferreira LS, Hayward AM, et al. 2011; Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 32: 1102-1109.
30. Krzeminski TF, Nozynski JK, Grzyb J, et al. 2008; Wide-spread myocardial remodeling after acute myocardial infarction in rat. Features for heart failure progression. Vasc Pharmacol 48: 100-108.
31. L'Heureux N, Dusserre N, Konig G, et al. 2006; Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 12: 361-365.
32. Laflamme MA, Murry CE. 2005; Regenerating the heart. Nat Biotechnol 23: 845-856.
33. Lang N, Pereira MJ, Lee Y, et al. 2014; A blood-resistant surgical glue for minimally invasive repair of vessels and heart defects. Sci Translat Med 6: 218ra216.
34. Lee KY, Mooney DJ. 2012; Alginate: properties and biomedical applications. Progr Polym Sci 37: 106-126.
35. Lee RJ, Hinson A, Helgerson S, et al. 2012; Polymer-based restoration of left ventricular mechanics. Cell Transpl 22: 529-533.
36. Leor J, Landa N, Cohen S. 2006; Renovation of the injured heart with myocardial tissue engineering. Expert Rev Cardiovasc Therap 4: 239-252.
37. Leor J, Tuvia S, Guetta V, et al. 2009; Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in swine. J Am Coll Cardiol 54: 1014-1023.
38. Lesman A, Habib M, Caspi O, et al. 2010; Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng A 16: 115-125.
39. Li Z, Guan J. 2011; Hydrogels for cardiac tissue engineering. Polymers 3: 740-761.
40. Liau B, Zhang D, Bursac N. 2012; Functional cardiac tissue engineering. Regen Med 7: 187-206.
41. Lu WN, Lü SH, Wang HB, et al. 2009; Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng A 15: 1437-1447.
42. Madden LR, Mortisen DJ, Sussman EM, et al. 2010; Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A 107: 15211-15216.
43. Maidhof R, Tandon N, Lee EJ, et al. 2011; Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J Tissue Eng Regen Med 6: e12-23.
44. Marsano A, Maidhof R, Wan LQ, et al. 2010; Scaffold stiffness affects the contractile function of three-dimensional engineered cardiac constructs. Biotechnol Progr 26: 1382-1390.
45. Martinez EC, Kofidis T. 2011; Adult stem cells for cardiac tissue engineering. J Mol Cell Cardiol 50: 312-319.
46. Masuda S, Shimizu T, Yamato M, et al. 2008; Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev 60: 277-285.
47. Mathers CD, Loncar D. 2006; Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.
48. Matsubayashi K, Fedak PW, Mickle DA, et al. 2003; Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 108(suppl 1): II219-225.
49. Menasche P 2008; Current status and future prospects for cell transplantation to prevent congestive heart failure. Semin Thorac Cardiovasc Surg 20: 131-137.
50. Miyagi Y, Chiu LL, Cimini M, et al. 2011; Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials 32: 1280-1290.
51. Morritt AN, Bortolotto SK, Dilley RJ, et al. 2007; Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 115: 353-360.
52. Nelson DM, Ma Z, Fujimoto KL, et al. 2011; Intra-myocardial biomaterial injection therapy in the treatment of heart failure: materials, outcomes and challenges. Acta Biomater 7: 1-15.
53. Ng SL, Narayanan K, Gao S, et al. 2011; Lineage restricted progenitors for the repopulation of decellularized heart. Biomaterials 32: 7571-7580.
54. Odedra D, Chiu LLY, Reis LA, et al. 2011; Cardiac tissue engineering. In Biomaterials for Tissue Engineering Applications: A Review of Past and Future Trends, 1st edn, Burdick JA, Mauck RL (eds). Springer: Vienna; 562.
55. Ott HC, Matthiesen TS, Goh SK, et al. 2008; Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14: 213-221.
56. Ozawa T, Mickle DA, Weisel RD, et al. 2002; Optimal biomaterial for creation of autologous cardiac grafts. Circulation 106: I176-182.
57. Pantilat SZ, Steimle AE. 2004; Palliative care for patients with heart failure. J Am Med Assoc 291: 2476-2482.
58. Park H, Larson BL, Guillemette MD, et al. 2011; The significance of pore microarchitecture in a multi-layered elastomeric scaffold for contractile cardiac muscle constructs. Biomaterials 32: 1856-1864.
59. Patten RD, Aronovitz MJ, Deras-Mejia L, et al. 1998; Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol 274: H1812-1820.
60. Radisic M, Malda J, Epping E, et al. 2006; Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 93: 332-343.
61. Rane AA, Chuang JS, Shah A, et al. 2011; Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction. PLoS One 6: e21571.
62. Reis LA, Chiu LLY, Liang Y, et al. 2012; A peptide-modified chitosan-collagen hydrogel for cardiac cell culture and delivery. Acta Biomater 8: 1022-1036.
63. Riehl BD, Park JH, Kwon IK, et al. 2012; Mechanical stretching for tissue engineering: two-dimensional and three-dimensional constructs. Tissue Eng B Rev 18: 288-300.
64. Roger VL, Go AS, Lloyd-Jones, DM, et al. 2012; Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 125: e2-220.
65. Rufaihah AJ, Vaibavi SR, Plotkin M, et al. 2013; Enhanced infarct stabilization and neovascularization mediated by VEGF-loaded PEGylated fibrinogen hydrogel in a rodent myocardial infarction model. Biomaterials 34: 8195-8202.
66. Sanchez PL, Fernandez-Santos ME, Costanza S, et al. 2012; Characterization and biocompatibility of perfusion-decellularized human heart matrix: toward bioengineering perfusable human heart grafts. J Am Coll Cardiol 59: E857-857.
67. Sapir Y, Kryukov O, Cohen S. 2011; Integration of multiple cell-matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration. Biomaterials 32: 1838-1847.
68. Segers VF, Lee RT. 2011; Biomaterials to enhance stem cell function in the heart. Circ Res 109: 910-922.
69. Sekine H, Shimizu T, Sakaguchi K, et al. 2013; In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nat Commun 4: 1399.
70. Shiba Y, Hauch KD, Laflamme MA. 2009; Cardiac applications for human pluripotent stem cells. Curr Pharmaceut Design 15: 2791-2806.
71. Shimizu T, Yamato M, Isoi Y, et al. 2002; Fabrication of pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90: E40-48.
72. Singelyn JM, Sundaramurthy P, Johnson TD, et al. 2012; Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J Am Coll Cardiol 59: 751-763.
73. Sutton MG, Sharpe N. 2000; Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101: 2981-2988.
74. Tandon N, Marsano A, Maidhof R, et al. 2011; Optimization of electrical stimulation parameters for cardiac tissue engineering. J Tissue Eng Regen Med 5: e115-125.
75. Treiser M, Abramson S, Langer R, et al. 2013; Degradable and resorbable biomaterials. In Biomaterials Science, 3rd edn, Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (eds). Academic Press: New York; 179-195.
76. Venugopal JR, Prabhakaran MP, Mukherjee S, et al. 2011; Biomaterial strategies for alleviation of myocardial infarction. J Roy Soc Interface 9: 1-19.
77. Vunjak-Novakovic G, Tandon N, Godier A, et al. 2010; Challenges in cardiac tissue engineering. Tissue Eng B Rev 16: 169-187.
78. Wainwright JM, Czajka CA, Patel UB, et al. 2010; Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng C Methods 16: 525-532.
79. Wall ST, Walker JC, Healy KE, et al. 2006; Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 114: 2627-2635.
80. Wang T, Jiang XJ, Tang QZ, et al. 2009; Bone marrow stem cells implantation with α-cyclodextrin/MPEG-PCL-MPEG hydrogel improves cardiac function after myocardial infarction. Acta Biomater 5: 2939-2944.
81. Weymann A, Loganathan S, Takahashi H, et al. 2011; Development and evaluation of a perfusion decellularization porcine heart model - generation of three-dimensional myocardial neoscaffolds. Circ J 75: 852-860.
82. WHO (World Health Organization). 2011a; The top 10 causes of death. In WHO Fact Sheet No. 310. WHO: Geneva.
83. WHO (World Health Organization). 2011b; In Global Status Report on Non-communicable Diseases, 2010, Alwan A (ed.). WHO: Geneva; 176.
84. Williams DF, European Society for Biomaterials. 1987; Definitions in biomaterials. In Proceedings of a Consensus Conference of the European Society for Biomaterials, Chester, UK, 3-5 March 1986. Elsevier: New York.
85. Wilson SR, Mudge GH Jr, Stewart GC, et al. 2009; Evaluation for a ventricular assist device: selecting the appropriate candidate. Circulation 119: 2225-2232.
86. Wu J, Zeng F, Huang XP, et al. 2011; Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. Biomaterials 32: 579-586.
87. Yeo Y, Geng WL, Ito T, et al. 2007; Photocrosslinkable hydrogel for myocyte cell culture and injection. J Biomed Mater Res B Appl Biomater 81B: 312-322.
88. Yeong WY, Sudarmadji N, Yu HY, et al. 2010; Porous polycaprolactone scaffold for cardiac tissue engineering fabricated by selective laser sintering. Acta Biomater 6: 2028-2034.
89. Yildirim Y, Naito H, Didie M, et al. 2007; Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 116: I16-23.
90. Yu J, Christman KL, Chin E, et al. 2009; Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg 137: 180-187.
91. Zammaretti P, Jaconi M. 2004; Cardiac tissue engineering: regeneration of the wounded heart. Curr Opin Biotechnol 15: 430-434.
92. Zimmermann WH, Schneiderbanger K, Schubert P, et al. 2002; Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90: 223-230.
93. Zimmermann WH, Melnychenko I, Wasmeier G, et al. 2006; Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12: 452-458.